From July 1, 2023 to September 30, 2023, the company has repurchased 175,910 shares, representing 0.22% for $0.4 million. With this, the company has completed the repurchase of 3,056,903 shares, representing 3.86% for $5.8 million under the buyback announced on November 28, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.525 USD | +1.81% | +5.91% | +13.57% |
May. 08 | Transcript : Standard BioTools Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.57% | 949M | |
+11.81% | 225B | |
+11.74% | 186B | |
+13.69% | 135B | |
+26.61% | 107B | |
+0.91% | 63.56B | |
+6.74% | 51.32B | |
+12.87% | 51.04B | |
+8.89% | 43.3B | |
+4.11% | 36.99B |
- Stock Market
- Equities
- LAB Stock
- News Standard BioTools Inc.
- Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on November 28, 2022.